
ActiumHealth is the largest AI agent patient communication platform, automating over 50 million patient calls and 100 million messages. Their AI-powered platform works alongside healthcare teams to scale patient interactions, reduce burnout, and ensure every call is handled with care. Key products include ActiumHealth Interact for AI-driven conversational agents, ActiumHealth Activate for patient outreach, and ActiumHealth Illuminate for analytics. The company differentiates itself by automating approximately 70% of routine calls and integrating seamlessly with existing systems, offering a unified platform for inbound and outbound communications. They are a division of Syllable, founded in 2017, and headquartered in Mountain View, CA.

ActiumHealth is the largest AI agent patient communication platform, automating over 50 million patient calls and 100 million messages. Their AI-powered platform works alongside healthcare teams to scale patient interactions, reduce burnout, and ensure every call is handled with care. Key products include ActiumHealth Interact for AI-driven conversational agents, ActiumHealth Activate for patient outreach, and ActiumHealth Illuminate for analytics. The company differentiates itself by automating approximately 70% of routine calls and integrating seamlessly with existing systems, offering a unified platform for inbound and outbound communications. They are a division of Syllable, founded in 2017, and headquartered in Mountain View, CA.
What they do: AI-driven patient communication platform automating inbound/outbound voice, SMS, chat, and email
Scale: Claims >50 million patient calls and 100 million messages automated
Founded / HQ: Founded 2017; headquartered in Mountain View, CA
Parent / status: Division of Syllable
Funding: Reported total funding $35M; Series B May 18, 2021 led by TT Capital Partners
Patient communication and engagement workflows for health systems and large medical practices
2017
Healthcare IT / Patient Engagement
Series B reported in May 2021; external reporting cites $25M for the round.
“TT Capital Partners and Adams Street Partners are recorded investors; a MemorialCare affiliate is noted as a customer-investor in a case study.”